1. Home
  2. Analysis
  3. Vinblastine-sulfate
  4. Pancytopenia

Vinblastine sulfate and Pancytopenia - a phase IV clinical study of FDA data

Summary:

Pancytopenia is reported as a side effect among people who take Vinblastine sulfate (vinblastine sulfate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Etoposide, and have Hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Pancytopenia when taking Vinblastine sulfate. It is created by eHealthMe based on reports of 2,781 people who have side effects when taking Vinblastine sulfate from the FDA, and is updated regularly.

What is Vinblastine sulfate?

Vinblastine sulfate has active ingredients of vinblastine sulfate. eHealthMe is studying from 2,788 Vinblastine sulfate users. Check the latest studies of Vinblastine sulfate.

What is Pancytopenia?

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets) is found to be associated with 1,793 drugs and 2,430 conditions by eHealthMe. Check the latest studies of Pancytopenia.

On Jul, 06, 2026

2,781 people reported to have side effects when taking Vinblastine sulfate.
Among them, 94 people (3.38%) have Pancytopenia.

Could Vinblastine sulfate cause Pancytopenia?

Among these 94 people:

How long have people been on Vinblastine sulfate when they have Pancytopenia? *

  • < 1 month: 81.82 %
  • 1 - 6 months: 9.09 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 9.09 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Pancytopenia when taking Vinblastine sulfate? *

  • female: 51.28 %
  • male: 48.72 %

What is the age of people who have Pancytopenia when taking Vinblastine sulfate? *

  • 0-1: 1.49 %
  • 2-9: 4.48 %
  • 10-19: 4.48 %
  • 20-29: 28.36 %
  • 30-39: 4.48 %
  • 40-49: 10.45 %
  • 50-59: 16.42 %
  • 60+: 29.85 %

What are other drugs people take besides Vinblastine sulfate? *

  1. Etoposide: 40 people, 42.55%
  2. Cisplatin: 39 people, 41.49%
  3. Cytarabine: 20 people, 21.28%
  4. Bleomycin Sulfate: 20 people, 21.28%
  5. Prednisolone: 20 people, 21.28%
  6. Dacarbazine: 19 people, 20.21%
  7. Cyclophosphamide: 17 people, 18.09%
  8. Methotrexate: 14 people, 14.89%
  9. Doxorubicin Hydrochloride: 14 people, 14.89%
  10. Cladribine: 13 people, 13.83%

What are other side effects people have besides Pancytopenia? *

  1. Fever: 16 people, 17.02%
  2. Sepsis (a severe blood infection that can lead to organ failure and death): 14 people, 14.89%
  3. Acute Kidney Failure: 10 people, 10.64%
  4. Fatigue (feeling of tiredness): 8 people, 8.51%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 8 people, 8.51%
  6. Cellulitis (infection under the skin): 7 people, 7.45%
  7. Septic Shock (shock due to blood infection): 6 people, 6.38%
  8. Hypotension (abnormally low blood pressure): 6 people, 6.38%
  9. Febrile Neutropenia (fever with reduced white blood cells): 6 people, 6.38%
  10. Mucosal Inflammation (infection of mucous membrane): 6 people, 6.38%

What are the existing conditions these people have? *

  1. Langerhans' Cell Histiocytosis: 14 people, 14.89%
  2. Hodgkin's Lymphoma (cancer originating from white blood cells): 14 people, 14.89%
  3. Ovarian Cancer (cancer of ovary): 8 people, 8.51%
  4. Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 4 people, 4.26%
  5. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 3 people, 3.19%
  6. Non-Hodgkin's Lymphoma Stage Iv (malignant (cancer) cells form in the lymph system- stageiv): 2 people, 2.13%
  7. Small Cell Carcinoma (small cell cancer tumour): 2 people, 2.13%
  8. Castleman's Disease (a disease of lymph nodes and related tissues): 2 people, 2.13%
  9. Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 2 people, 2.13%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Vinblastine sulfate and have Pancytopenia?

- Check whether Pancytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vinblastine sulfate:

Pancytopenia treatments and more:

How severe was Pancytopenia and when was it recovered:

Expand to all the drugs that have ingredients of vinblastine sulfate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vinblastine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pancytopenia:

Browse all the conditions that are associated with Pancytopenia:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on vinblastine sulfate (the active ingredients of Vinblastine sulfate) and Vinblastine sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.